Priego BR, Rincón LR, errano A, Torres GB, Haddad TJL, Del Vecchyo CC

Language: Spanish
References: 13
Page: 112-119
PDF size: 446.01 Kb.

ABSTRACT

Breast adjuvant disease is a deforming, incapacitating and in some advanced cases, a mortal condition that affects our population who tries by all means to comply with a commercial and cultural expectation of beauty at a low cost. At the Plastic and Reconstructive Surgery Service in the Hospital General de México O.D. we have treated a total of 123 female patients with adjuvant disease in the last 5 years. 56 patients (45.5%), had direct injury of mammary glands related to the injection of the modeling material. The propose classification was made in order to expedite the reconstructive decision-making based on our experience. According to the level of tissue affection by adjuvant material we created a classification considering the reconstructive needs due to clinic and radiologic parameters. A total of 44 reconstructive procedures were performed, 12 patients continue only under rheumatologic treatment and one is has no surgical treatment. Of the total patients who were operated 43 are satisfied with their surgical result and refer good functional and acceptable aesthetic results. We had one death in the second month after surgery related to adjuvant disease complications exacerbated by the surgical procedure.

REFERENCES

1. Ortiz MF. Management of patients with complications from injections of foreign materials into the breast. Plast Reconstr Surg 1972; 50: 42.

2. Hage J, Kanhai CJ, Oen AL et al. The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals. Plast Reconstr Surg 2001; 107(3): 734-741.

3. Enríquez J, Alcalá D, González KI y cols. Lipogranuloma esclerosante por modelantes. Rev Cent Dermatol Pascua 2007; 16(1): 19-23.

4. Rees T, Ballantyne D, Seidman I. Silicone fluid: response to massive subcutaneous injections of dimethylpolysiloxane fluid in animals. Plast Reconstr Surg 1965; 36(3): 330-338.

5. Rees T, Ashley F, Braley S, Goulian D, Ballantyne D. The present status of silicone fluid in soft tissue augmentation. Plast Reconstr Surg 1967; 39(4): 411-420.

6. Rees T, Ben-Hur N, Ballantyne D, Seidman I. Local and systemic effects of dimethylpolysiloxane fluid in mice. 1967; 39(4): 423-426.

7. Rees T, Ballantyne D, Hawthorne G. Silicone fluid research. Plast Reconstr Surg 1970; 46(1): 50-56.

8. Behar T, Anderson EE, Barwick WJ, Sclerosing lipogranulomatosis: a case report of scrotal injection of automobile transmission fluid and literature review of subcutaneous injection of oils. Plast Reconstr Surg 1993; 91(2): 352-361.

9. Cabral A. Clinical histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Rev Invest Clin 1994; 46(4): 257-266.

10. Sergott T, Limoli J, Baldwin C, Laub D. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 1986; 78(1): 104:114.

11. Ho WS, Chan CW, Law BKB. Management of paraffinoma of the breast: 10 years’ experience. Br J Plast 2001; 54: 232-234.

12. Gutiérrez E, Durán H, Duffy BE y cols. Mastectomía y reconstrucción inmediata bilateral en lipogranuloma esclerosante mamario causado por inyección de modelantes. Reporte de un caso. Cir Plast 2003; 13: 123-127.

13. Haddad JL, Nieto A, Saade A y cols. Reconstrucción mamaria con colgajo de TRAM bilateral en pacientes mastectomizadas por mastopatía por modelantes. Ann Med 2006; 51(1): 24-28.